Actinium Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
/ 
Frequently asked questions
To buy Actinium Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Actinium Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Actinium Pharmaceuticals Inc. is ATNM:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Actinium Pharmaceuticals Inc. has its primary listing on NYSE American. You can trade Actinium Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Actinium Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Actinium Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Actinium Pharmaceuticals Inc..